Prevention of Stroke in Patients with High-Risk Atrial Fibrillation
- 8 January 2010
- journal article
- review article
- Published by Springer Nature in Current Neurology and Neuroscience Reports
- Vol. 10 (1) , 34-39
Abstract
Atrial fibrillation (AF) causes nearly 10% of all ischemic strokes. Long-term oral anticoagulation with warfarin currently is the best treatment for preventing stroke in patients with AF and other stroke risk factors. However, many eligible patients do not receive warfarin, and some patients with AF are unsuitable for this treatment. Recent clinical trials have tested alternatives to long-term warfarin, and some new treatment options have emerged. Nonpharmacologic approaches to stroke prevention in atrial fibrillation also are under development. In addition, new diagnostic modalities may detect paroxysmal AF with more sensitivity, potentially expanding the population to be treated and the potential impact of stroke preventive strategies on the population. This review provides a practical guide to current treatment and diagnostic options.Keywords
This publication has 23 references indexed in Scilit:
- Analysis of Stroke in ATHENA: A Placebo-Controlled, Double-Blind, Parallel-Arm Trial to Assess the Efficacy of Dronedarone 400 mg BID for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in Patients With Atrial Fibrillation/Atrial FlutterCirculation, 2009
- Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trialThe Lancet, 2009
- Left Atrial Appendage Occlusion — Closure or Just the Beginning?New England Journal of Medicine, 2009
- Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or strokeNeurology, 2008
- Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic RangeCirculation, 2008
- ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial InfarctionCirculation, 2007
- Risk of Thromboembolic Events After Percutaneous Left Atrial Radiofrequency Ablation of Atrial FibrillationCirculation, 2006
- Ximelagatran vs Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial FibrillationJAMA, 2005
- Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillationJACC, 2003
- Increased Expression of P-Selectin on Platelets Is a Risk Factor for Silent Cerebral Infarction in Patients With Atrial FibrillationCirculation, 1998